These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20615887)

  • 1. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
    Bjørge T; Lukanova A; Jonsson H; Tretli S; Ulmer H; Manjer J; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Häggström C; Stattin P; Engeland A
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1737-45. PubMed ID: 20615887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
    Bjørge T; Lukanova A; Tretli S; Manjer J; Ulmer H; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Jonsson H; Häggström C; Stattin P; Engeland A
    Int J Epidemiol; 2011 Dec; 40(6):1667-77. PubMed ID: 21984693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and endometrial carcinoma.
    Bjørge T; Stocks T; Lukanova A; Tretli S; Selmer R; Manjer J; Rapp K; Ulmer H; Almquist M; Concin H; Hallmans G; Jonsson H; Stattin P; Engeland A
    Am J Epidemiol; 2010 Apr; 171(8):892-902. PubMed ID: 20219764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
    Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
    Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).
    Lindkvist B; Almquist M; Bjørge T; Stocks T; Borena W; Johansen D; Hallmans G; Engeland A; Nagel G; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
    Cancer Causes Control; 2013 Jan; 24(1):107-16. PubMed ID: 23149498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
    Nagel G; Bjørge T; Stocks T; Manjer J; Hallmans G; Edlinger M; Häggström C; Engeland A; Johansen D; Kleiner A; Selmer R; Ulmer H; Tretli S; Jonsson H; Concin H; Stattin P; Lukanova A
    Br J Dermatol; 2012 Jul; 167(1):59-67. PubMed ID: 22530854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
    Häggström C; Stocks T; Rapp K; Bjørge T; Lindkvist B; Concin H; Engeland A; Manjer J; Ulmer H; Selmer R; Tretli S; Hallmans G; Jonsson H; Stattin P
    Int J Cancer; 2011 Apr; 128(8):1890-8. PubMed ID: 20568111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
    Borena W; Strohmaier S; Lukanova A; Bjørge T; Lindkvist B; Hallmans G; Edlinger M; Stocks T; Nagel G; Manjer J; Engeland A; Selmer R; Häggström C; Tretli S; Concin H; Jonsson H; Stattin P; Ulmer H
    Int J Cancer; 2012 Jul; 131(1):193-200. PubMed ID: 21805476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women's Lifestyle and Health cohort study.
    Margolis KL; Mucci L; Braaten T; Kumle M; Trolle Lagerros Y; Adami HO; Lund E; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):27-32. PubMed ID: 15668472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can).
    Stocks T; Lukanova A; Bjørge T; Ulmer H; Manjer J; Almquist M; Concin H; Engeland A; Hallmans G; Nagel G; Tretli S; Veierød MB; Jonsson H; Stattin P;
    Cancer; 2011 Jun; 117(11):2398-407. PubMed ID: 24048787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study on metabolic factors and risk of prostate cancer.
    Häggström C; Stocks T; Ulmert D; Bjørge T; Ulmer H; Hallmans G; Manjer J; Engeland A; Nagel G; Almqvist M; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
    Cancer; 2012 Dec; 118(24):6199-206. PubMed ID: 23090855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
    Arnlöv J; Ingelsson E; Sundström J; Lind L
    Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can).
    Almquist M; Johansen D; Björge T; Ulmer H; Lindkvist B; Stocks T; Hallmans G; Engeland A; Rapp K; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
    Cancer Causes Control; 2011 May; 22(5):743-51. PubMed ID: 21380729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project.
    Johansen D; Stocks T; Jonsson H; Lindkvist B; Björge T; Concin H; Almquist M; Häggström C; Engeland A; Ulmer H; Hallmans G; Selmer R; Nagel G; Tretli S; Stattin P; Manjer J
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2307-17. PubMed ID: 20826833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study.
    Edlinger M; Strohmaier S; Jonsson H; Bjørge T; Manjer J; Borena WT; Häggström C; Engeland A; Tretli S; Concin H; Nagel G; Selmer R; Johansen D; Stocks T; Hallmans G; Stattin P; Ulmer H
    J Hypertens; 2012 Feb; 30(2):290-6. PubMed ID: 22179083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.